Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Detalhes bibliográficos
Autor principal:	Hoque, Ismoth Ara
Outros Autores:	Azam, Faruque
Formato:	Tese
Idioma:	English
Publicado em:	Brac University 2024
Assuntos:	Lung cancer PFS ORR NSCLC subtypes Lungs > Cancer Clinical trials > Statistical methods
Acesso em linha:	http://hdl.handle.net/10361/23164

Registros relacionados

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
por: Paul, Pulock
Publicado em: (2024)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
por: Rahman, Tasnim
Publicado em: (2024)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
por: Karim, Samia Binte
Publicado em: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
por: Flora, Sanzida Alam
Publicado em: (2024)

Molecules associated with the development of lung cancer
por: Rahman, Adree, et al.
Publicado em: (2023)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
por: Das, Reshita
Publicado em: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
por: Jeba, Joynob
Publicado em: (2017)

A review on targeted therapies for lung cancer
por: Ashraf, Anushey
Publicado em: (2023)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
por: Razna, Amrin Islam
Publicado em: (2019)

Potential of liposomes for the treatment of lung cancer- a review
por: Mim, Shanzida
Publicado em: (2023)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
por: Tania, Umme
Publicado em: (2023)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
por: Zangmo, Thinley
Publicado em: (2024)

A review on recent advances in drugs for lung cancer treatment
por: Noor, Fouzia
Publicado em: (2024)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
por: Pial, Sazia Afrin
Publicado em: (2018)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
por: Shabnam, Musharrat
Publicado em: (2018)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
por: Bristy, Israt Zerin
Publicado em: (2021)

Immunotherapy in the Management of Lung Cancer
por: Tasnim, Humayra
Publicado em: (2022)

Lung cancer detection and classification using machine learning
por: Arefin, Mahbubul, et al.
Publicado em: (2023)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
por: Mukti, Roushney Fatima, et al.
Publicado em: (2016)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
por: Nandy, Aditi
Publicado em: (2022)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
por: Shobnam, Sohana
Publicado em: (2024)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
por: Hasan, Sakib
Publicado em: (2024)

Comparative efficacy of Sorafenib, and Lenvatinib in Hepatocellular Carcinoma: a meta-analysis
por: Monayem, Kazi Fahim
Publicado em: (2024)

A review on the potential of repurposing of metformin for colon cancer and breast cancer
por: Oishy, Jannatun Noor
Publicado em: (2024)

Tuberculosis associates with both airflow obstruction and low lung function: BOLD results
por: F. S. Amaral, André, et al.
Publicado em: (2017)

A comparative study of lung cancer prediction using deep learning
por: Mugdho, Aka Mohammad, et al.
Publicado em: (2023)

Semantic segmentation with attention dense U-net for lung extraction from X-ray images
por: Auvy, Akib Al Mahmud, et al.
Publicado em: (2023)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
por: Hossain, Safa Binte
Publicado em: (2019)

Deep 3D convolutional neural network in early detection of Lung cancer
por: Hossain, Khandoker Jobayer, et al.
Publicado em: (2019)

Statistics and informatics in molecular cancer research

Smart biomedical device to predict lung diseases, COVID-19 and diabetes by using machine learning algorithms
por: Hossain, Ashraful, et al.
Publicado em: (2024)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
por: Hasan, Amit
Publicado em: (2024)

Machine learning as an indicator for breast cancer prediction
por: Shadman, Tahsin Mohammed, et al.
Publicado em: (2019)

The uses of bacteria in cancer therapy
por: Saha, Shimul, et al.
Publicado em: (2021)

Safety and efficacy of cisplatin combinations with vinorelbine, paclitaxel and gemcitabine – a systematic review and meta-analysis
por: Islam, Inaya
Publicado em: (2024)

Cancer risk factors: a critical review
por: Tabassum, Tahsina
Publicado em: (2017)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
por: Nawar, Anika
Publicado em: (2019)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
por: Abir, Shifaty Nur
Publicado em: (2024)

Targeting BRAFV600E in the treatment of CRC
por: Roja, Mashwiyat Samrin
Publicado em: (2024)

The impact of cell penetrating peptides in prospective cancer therapy: a review
por: Nashrah, Zannatul
Publicado em: (2023)